Manulife (Manufacturers Life Insurance)’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-20,343
| Closed | -$61K | – | 3011 |
|
|
2023
Q3 | $61K | Hold |
20,343
| – | – | ﹤0.01% | 2929 |
|
|
2023
Q2 | $50K | Sell |
20,343
-4,694
| -19% | -$11.5K | ﹤0.01% | 2949 |
|
|
2023
Q1 | $56.6K | Hold |
25,037
| – | – | ﹤0.01% | 2844 |
|
|
2022
Q4 | $88.6K | Sell |
25,037
-5,393
| -18% | -$19.1K | ﹤0.01% | 2823 |
|
|
2022
Q3 | $1.11M | Sell |
30,430
-275
| -0.9% | -$10K | ﹤0.01% | 1562 |
|
|
2022
Q2 | $590K | Buy |
30,705
+16,499
| +116% | +$317K | ﹤0.01% | 1933 |
|
|
2022
Q1 | $379K | Buy |
+14,206
| New | +$379K | ﹤0.01% | 2360 |
|
|
2021
Q4 | – | Sell |
-8,407
| Closed | -$220K | – | 3169 |
|
|
2021
Q3 | $220K | Sell |
8,407
-413
| -5% | -$10.8K | ﹤0.01% | 2918 |
|
|
2021
Q2 | $282K | Buy |
8,820
+513
| +6% | +$16.4K | ﹤0.01% | 2857 |
|
|
2021
Q1 | $292K | Sell |
8,307
-473
| -5% | -$16.6K | ﹤0.01% | 2638 |
|
|
2020
Q4 | $282K | Buy |
8,780
+658
| +8% | +$21.1K | ﹤0.01% | 2556 |
|
|
2020
Q3 | $306K | Hold |
8,122
| – | – | ﹤0.01% | 2282 |
|
|
2020
Q2 | $350K | Buy |
+8,122
| New | +$350K | ﹤0.01% | 2147 |
|